Trials / Completed
CompletedNCT04426422
Effect of Metformin on Gut Microbiota Changes and Glycemic Control of Newly Diagnosed Type 2 Diabetes
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Shenzhen People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study was aimed to investigate the effect of metformin on the gut microbiota and glycemic control in newly diagnosed type 2 diabetes patients.
Detailed description
This study was aimed to investigate the effect of metformin on the gut microbiota and glycemic control in newly diagnosed type 2 diabetes patients. All the recurited patients were treated with metformin 1500-2000mg daily for 3 months. Stool specimens and blood samples were collected at the beginning and 3 months later.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metformin Hydrochloride | treated with metformin 1500-2000mg daily |
Timeline
- Start date
- 2017-03-01
- Primary completion
- 2018-06-30
- Completion
- 2018-09-30
- First posted
- 2020-06-11
- Last updated
- 2020-06-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04426422. Inclusion in this directory is not an endorsement.